Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Ica1lem1flox/Cya
Common Name:
Ica1l-flox
Product ID:
S-CKO-14801
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ica1l-flox
Strain ID
CKOCMP-70375-Ica1l-B6J-VA
Gene Name
Ica1l
Product ID
S-CKO-14801
Gene Alias
1700030B17Rik; Als2cr15; b2b3465Clo
Background
C57BL/6JCya
NCBI ID
70375
Modification
Conditional knockout
Chromosome
1
Phenotype
MGI:1917625
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ica1lem1flox/Cya mice (Catalog S-CKO-14801) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000027172
NCBI RefSeq
NM_027407
Target Region
Exon 3
Size of Effective Region
~2.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Ica1l, which has sequence similarities to ICA69 (also known as ICA1), is a gene with diverse functions. It forms BAR-domain complexes with PICK1, and this interaction is crucial for acrosome formation in spermiogenesis. Ica1l is expressed in testes and brain, and in testes, it is the major binding partner for PICK1 [3].

ICA1L has been associated with several diseases. In genetic studies, it was found that the expression of ICA1L is associated with lacunar stroke, a subtype of small-vessel stroke, through transcriptome-wide association study (TWAS) [1]. An integrative analysis also revealed that ICA1L was associated with small-vessel stroke (SVS) based on brain-derived data at both protein and transcriptional levels [2]. Additionally, a proteome-wide association study (PWAS) showed that ICA1L is significantly associated with SVS and non-lobar intracerebral haemorrhage (ICH), and the SMR results indicated a causal association of its protein expression levels in the brain with these traits [4]. In cellular myoid neoplasms, novel SRF-ICA1L fusions were identified in some spindle cell tumors, which may define a subset of neoplasms composed of immature smooth muscle cells and have potential for malignant behavior [5]. In the context of neurodegenerative and neurodevelopmental disorders, ICA1L was identified as a potential drug target in studies related to attention deficit hyperactivity disorder (ADHD) and Alzheimer's disease. In ADHD, it provided protection against both ASD and ADHD, while in Alzheimer's disease, its brain protein abundance was found to be causal, but it was not recommended as a prioritized drug due to potential side effects [6,7].

In conclusion, Ica1l is important for acrosome formation during spermiogenesis. In disease contexts, Ica1l has been linked to various cerebrovascular and neurological conditions, such as small-vessel stroke, intracerebral haemorrhage, ADHD, and Alzheimer's disease, highlighting its potential as a biomarker or drug target in these areas. The study of Ica1l using genetic models, such as the ICA1L-knockout mouse model which demonstrated its role in sperm development, helps in understanding its function in both normal biological processes and disease conditions [3].

References:
1. Traylor, Matthew, Persyn, Elodie, Tomppo, Liisa, Lewis, Cathryn M, Markus, Hugh S. 2021. Genetic basis of lacunar stroke: a pooled analysis of individual patient data and genome-wide association studies. In The Lancet. Neurology, 20, 351-361. doi:10.1016/S1474-4422(21)00031-4. https://pubmed.ncbi.nlm.nih.gov/33773637/
2. Wu, Bang-Sheng, Chen, Shu-Fen, Huang, Shu-Yi, Dong, Qiang, Yu, Jin-Tai. 2022. Identifying causal genes for stroke via integrating the proteome and transcriptome from brain and blood. In Journal of translational medicine, 20, 181. doi:10.1186/s12967-022-03377-9. https://pubmed.ncbi.nlm.nih.gov/35449099/
3. He, Jing, Xia, Mengying, Tsang, Wai Hung, Chow, King Lau, Xia, Jun. 2015. ICA1L forms BAR-domain complexes with PICK1 and is crucial for acrosome formation in spermiogenesis. In Journal of cell science, 128, 3822-36. doi:10.1242/jcs.173534. https://pubmed.ncbi.nlm.nih.gov/26306493/
4. Cullell, Natalia, Gallego-Fábrega, Cristina, Cárcel-Márquez, Jara, Fernández-Cadenas, Israel, Krupinski, Jerzy. 2022. ICA1L Is Associated with Small Vessel Disease: A Proteome-Wide Association Study in Small Vessel Stroke and Intracerebral Haemorrhage. In International journal of molecular sciences, 23, . doi:10.3390/ijms23063161. https://pubmed.ncbi.nlm.nih.gov/35328582/
5. Suurmeijer, Albert J, Dickson, Brendan C, Swanson, David, Zhang, Lei, Antonescu, Cristina R. . Novel SRF-ICA1L Fusions in Cellular Myoid Neoplasms With Potential For Malignant Behavior. In The American journal of surgical pathology, 44, 55-60. doi:10.1097/PAS.0000000000001336. https://pubmed.ncbi.nlm.nih.gov/31478943/
6. Zhang, Chengcheng, Jian, Lingqi, Li, Xiaojing, Hu, Xun, Li, Tao. 2024. Mendelian randomization analysis of the brain, cerebrospinal fluid, and plasma proteome identifies potential drug targets for attention deficit hyperactivity disorder. In EBioMedicine, 105, 105197. doi:10.1016/j.ebiom.2024.105197. https://pubmed.ncbi.nlm.nih.gov/38876042/
7. Ge, Yi-Jun, Ou, Ya-Nan, Deng, Yue-Ting, Tan, Lan, Yu, Jin-Tai. 2022. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood. In Biological psychiatry, 93, 770-779. doi:10.1016/j.biopsych.2022.11.002. https://pubmed.ncbi.nlm.nih.gov/36759259/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest